| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11096-014-9958-1 |
| P698 | PubMed publication ID | 24853094 |
| P2093 | author name string | Supakit Wongwiwatthananukit | |
| Nakarin Sansanayudh | |||
| Nongluk Phetkrajaysang | |||
| Sarinee Krittiyanunt | |||
| P2860 | cites work | Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline | Q22306207 |
| Fortification of orange juice with vitamin D(2) or vitamin D(3) is as effective as an oral supplement in maintaining vitamin D status in adults | Q24618917 | ||
| Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D | Q24655075 | ||
| Vitamin D deficiency | Q27860616 | ||
| Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement | Q29619465 | ||
| Vitamin D deficiency: a worldwide problem with health consequences. | Q30368744 | ||
| Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials | Q33298477 | ||
| Serum 25-hydroxy vitamin d and insulin resistance, metabolic syndrome, and glucose intolerance among Arab Americans | Q33873212 | ||
| Decreased bioavailability of vitamin D in obesity | Q33916095 | ||
| Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient - a randomised, placebo-controlled trial | Q34019552 | ||
| Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. | Q34067652 | ||
| Vitamin D(3) is more potent than vitamin D(2) in humans | Q34156152 | ||
| Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol | Q34166759 | ||
| Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction | Q34316970 | ||
| Vitamin D2 is much less effective than vitamin D3 in humans | Q34365889 | ||
| Association of serum 25-hydroxyvitamin D levels with markers for metabolic syndrome in the elderly: a repeated measure analysis | Q36014472 | ||
| Evaluation of ergocalciferol or cholecalciferol dosing, 1,600 IU daily or 50,000 IU monthly in older adults | Q36158130 | ||
| Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004. | Q37351001 | ||
| Is plasma 25(OH) D related to adipokines, inflammatory cytokines and insulin resistance in both a healthy and morbidly obese population? | Q42838086 | ||
| Serum concentrations of vitamin D and parathyroid hormone and prevalent metabolic syndrome among adults in the United States | Q42869397 | ||
| No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D3 for 1 year | Q43168823 | ||
| Vitamin D deficiency in patients with Graves' disease: probably something more than a casual association | Q45732809 | ||
| Serum 25-hydroxyvitamin D levels in vitamin D-insufficient hip fracture patients after supplementation with ergocalciferol and cholecalciferol. | Q45920169 | ||
| Supplementation with cholecalciferol does not improve glycaemic control in diabetic subjects with normal serum 25-hydroxyvitamin D levels | Q46049413 | ||
| Supplementation with cholecalciferol does not result in weight reduction in overweight and obese subjects. | Q46213833 | ||
| The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency | Q46259166 | ||
| Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly. | Q46585248 | ||
| Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels. | Q51453737 | ||
| Serum concentration of vitamin D metabolites during treatment with vitamin D2 and D3 in normal premenopausal women. | Q53423633 | ||
| Vitamin D2 treatment for vitamin D deficiency and insufficiency for up to 6 years. | Q55052329 | ||
| Redefining vitamin D insufficiency | Q56087787 | ||
| P433 | issue | 4 | |
| P921 | main subject | ergocalciferol | Q139200 |
| metabolic syndrome | Q657193 | ||
| P304 | page(s) | 771-778 | |
| P577 | publication date | 2014-05-23 | |
| P1433 | published in | International Journal of Clinical Pharmacy | Q15759467 |
| P1476 | title | Comparative efficacy and safety of different doses of ergocalciferol supplementation in patients with metabolic syndrome | |
| P478 | volume | 36 |
Search more.